rs61998220

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001378030.1(CCDC78):​c.889C>T​(p.Arg297Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000852 in 1,611,818 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R297H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0043 ( 9 hom., cov: 33)
Exomes 𝑓: 0.00050 ( 6 hom. )

Consequence

CCDC78
NM_001378030.1 missense

Scores

2
5
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.17

Publications

2 publications found
Variant links:
Genes affected
CCDC78 (HGNC:14153): (coiled-coil domain containing 78) Involved in de novo centriole assembly involved in multi-ciliated epithelial cell differentiation and skeletal muscle contraction. Located in several cellular components, including centriole; deuterosome; and sarcolemma. Implicated in centronuclear myopathy 4. [provided by Alliance of Genome Resources, Apr 2022]
CCDC78 Gene-Disease associations (from GenCC):
  • congenital myopathy with internal nuclei and atypical cores
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • centronuclear myopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00530532).
BP6
Variant 16-724386-G-A is Benign according to our data. Variant chr16-724386-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 473269.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 650 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC78NM_001378030.1 linkc.889C>T p.Arg297Cys missense_variant Exon 9 of 14 ENST00000345165.10 NP_001364959.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC78ENST00000345165.10 linkc.889C>T p.Arg297Cys missense_variant Exon 9 of 14 5 NM_001378030.1 ENSP00000316851.5 H3BLT8

Frequencies

GnomAD3 genomes
AF:
0.00426
AC:
648
AN:
152190
Hom.:
9
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00308
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00136
AC:
335
AN:
246486
AF XY:
0.00109
show subpopulations
Gnomad AFR exome
AF:
0.0152
Gnomad AMR exome
AF:
0.000870
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00313
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000181
Gnomad OTH exome
AF:
0.000331
GnomAD4 exome
AF:
0.000495
AC:
723
AN:
1459510
Hom.:
6
Cov.:
35
AF XY:
0.000409
AC XY:
297
AN XY:
726092
show subpopulations
African (AFR)
AF:
0.0159
AC:
532
AN:
33480
American (AMR)
AF:
0.000940
AC:
42
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00146
AC:
58
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86238
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51224
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000809
AC:
9
AN:
1111910
Other (OTH)
AF:
0.00129
AC:
78
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
46
92
138
184
230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00427
AC:
650
AN:
152308
Hom.:
9
Cov.:
33
AF XY:
0.00419
AC XY:
312
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0145
AC:
603
AN:
41556
American (AMR)
AF:
0.00111
AC:
17
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00309
AC:
16
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68024
Other (OTH)
AF:
0.00284
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00129
Hom.:
3
Bravo
AF:
0.00504
ESP6500AA
AF:
0.0134
AC:
59
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00157
AC:
190
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 10, 2020
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital myopathy with internal nuclei and atypical cores Benign:1
Jan 14, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

CCDC78-related disorder Benign:1
Mar 11, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.36
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.31
T
Eigen
Benign
0.16
Eigen_PC
Benign
0.0055
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.88
D
MetaRNN
Benign
0.0053
T
MetaSVM
Benign
-0.68
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
4.2
PrimateAI
Benign
0.38
T
PROVEAN
Pathogenic
-6.1
D
REVEL
Benign
0.20
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.47
MVP
0.27
MPC
0.44
ClinPred
0.029
T
GERP RS
3.9
Varity_R
0.32
gMVP
0.29
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61998220; hg19: chr16-774386; API